MedTrace Logo

iPACK Block for Total Knee Arthroplasty

NCT06087562 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2023-10-18

No results posted yet for this study

Summary

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the rehabilitation process of the Interspace between the Popliteal Artery and Capsule of the Posterior Knee (iPACK) block in total knee arthroplasty.

Conditions

Interventions

DRUG

Ropivacaine 0.5% Injectable Solution 20mL

Ultrasound-guided iPACK block with 20mL of 0,5% ropivacaine

DRUG

0,9% normal saline 20mL

Ultrasound-guided placebo block with 20mL of 0,9% normal saline

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Małgorzata Domagalska, PhD · Department of Palliative Medicine, University of Medical Sciences, Poznań, Poland

  • Zbigniew Żaba, PhD · Department of Emergency Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2024-09-30
Completion
2024-12-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087562 on ClinicalTrials.gov